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Aryl hydrocarbon receptor (AhR) is a member of the basic helix-loop-helix-(bHLH) superfamily of transcription factors, which are associated with cellular responses to environmental stimuli, such as xenobiotics and oxygen levels. Unlike other members of bHLH, AhR is the only bHLH transcription factor that is known to be ligand activated. Early AhR studies focused on understanding the role of AhR in mediating the toxicity and carcinogenesis properties of the prototypic ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). In recent years, however, it has become apparent that, in addition to its toxicological involvement, AhR is highly receptive to a wide array of endogenous and exogenous ligands, and that its activation leads to a myriad of key host physiological functions. In this study, we review the current understanding of the functions of AhR in the mucosal immune system with a focus on its role in intestinal barrier function and intestinal immune cells, as well as in intestinal homeostasis.
Mucosal Immunology (2018) 11:1024-1038; https://doi.org/10.1038/s41385-018-0019-2 AHR SIGNALING PATHWAY Aryl hydrocarbon receptor (AhR) is widely expressed by different cell types throughout the body. [1] [2] [3] [4] Numerous genes are regulated by AhR, including those that encode xenobiotic metabolizing enzymes, such as Cytochrome P450 1A1 (Cyp1a1). 5, 6 The current model of canonical AhR cellular signaling is based on induction of the Cyp1a1 gene by AhR (Fig. 1) . 7, 8 In its inactive state, AhR is present in the cytoplasm and exists as a multi-protein complex with two chaperone proteins, heat shock protein (Hsp) 90 and the co-chaperone p23. 9 Upon binding to a ligand, the AhR complex undergoes a conformational change and subsequently translocates into the nucleus, where AhR, along with its ligand, is released from the rest of the chaperone proteins. 10 The remaining AhR:ligand complex heterodimerizes with its nuclear partner, Arnt. The AhR:ligand:Arnt complex eventually binds to the genomic region containing its specific DNA recognition site, called the dioxin response element (DRE), which is situated upstream of the Cyp1a1 and AhR repressor (AhRR) genes 8, 11, 12 (Fig. 1a) . The canonical AhR pathway also leads to the transcription of additional phase I xenobiotic metabolizing enzymes, such as Cyp1a2 and Cyp1b1, 8, 11, 12 as well as phase II enzymes, such as glutathione-S-transferase A, 13, 14 NAD(P)H: quinone oxidoreductase 1, 15 uridine 5′-diphosphate-glucuronosyltransferase 1A, 16 and aldehyde dehydrogenase 3 17 ( Fig. 1a) . These phase I and II enzymes have a role in the negative feedback loop of AhR signaling through metabolic depletion of the AhR ligand pool.
AhR has been characterized as a promiscuous receptor because of its propensity to bind to a variety of exogenous and endogenous ligands with different structures and physiochemical characteristics. 7 Despite its reactivity to different ligands, the canonical AhR signaling pathway is tightly controlled. In particular, three different checkpoints regulate AhR activation: (a) proteasomal degradation of AhR, (b) metabolism of ligands by CYP1A1, and (c) disruption of the AhR:Arnt complex by AhRR (Fig. 1a) . 18 Different studies have shown that several transcription start sites of AhR-responsive genes do not contain DRE, suggesting a non-canonical mechanism downstream of AhR. [19] [20] [21] [22] Indeed, after AhR ligand binding, AhR is able to directly interact with the hypophosphorylated retinoblastoma protein, leading to cell cycle arrest in the G1-phase in several cell lines, with a potential role in carcinogenesis control 19, 23 (Fig. 1b) . A direct interaction of AhR with nuclear factor-κB (NF-κB) was also described, inducing the expression of cytokines and chemokines, such as Bcell-activating factor of the tumor necrosis factor family, Blymphocyte chemoattractant, CC-chemokine ligand 1 (CCL1), and the transcription factor interferon responsive factor, 24 and decreasing the expression of Cyp1A1 25 ( Fig. 1c ). AhR has also been shown to exhibit anti-estrogenic effects, notably by inducing degradation of the estrogen receptor through an E3 ubiquitin ligase-like activity 26 ( Fig. 1d) . Finally, an interaction between AhR and the tumor suppressor Kruppel-like factor 6 (KLF6) at the non-consensus DRE has been characterized. 27 KLF6 regulates the transcription of genes involved in different processes, including cellular proliferation, differentiation, and apoptosis, 28, 29 and KLF6 mutations are linked to a number of cancers, such as hepatocellular carcinoma, 30 gastric cancer, 31 and colorectal cancer. 32 Therefore, KLF6 is a tumor suppressor 33 that can activate expression of p21 cip1 in an AhR-dependent manner, which leads to the inhibition of cell cycle progression 34 ( Fig. 1e) . These data suggest that AhR and KLF6 are partners in anti-tumor signaling pathways.
Therefore, activation of AhR by a ligand can induce canonical and/or non-canonical pathways and subsequent transcriptional events. Additional studies are needed to determine the contribution of each of these signaling pathways to the effects of AhR agonists.
AHR LIGANDS
Exogenous synthetic ligands AhR ligands have varying levels of affinity and reactivity. To date, the majority of high-affinity AhR ligands are synthetic ligands, which are formed as a result of non-biological activity and include environmental contaminants, such as halogenated aromatic hydrocarbon (HAH) and polycyclic aromatic hydrocarbon (PAH). 7, 35, 36 Through an interaction with NF-κB, AhR induces the expression of cytokines and chemokines, such as BAFF, BLC, CCL1, and IFR3. The AhR/NF-κB interaction also induces decreased expression of Cyp1A1. BAFF, B-cell-activating factor of the tumor necrosis factor family; BLC, Blymphocyte chemoattractant; CCL1, CC-chemokine ligand 1; IFR3, interferon responsive factor; NF-κB, nuclear factor-κB. d Ligand-activated AhR binds ER and promotes the proteolysis of ER by assembling a ubiquitin ligase complex. ER, estrogen receptor. e After ligand binding, AhR dimerizes with KLF6 and binds genomic regions containing NC-DRE that regulate the expression of target genes, such as p21 cip1 , which mediate cell cycle control. KLF6, tumor suppressor Kruppel-like factor 6; NC-DRE, non-consensus DRE physiology are not yet clearly defined. Nonetheless, the identification of these synthetic AhR ligands emphasized the structural diversity of AhR ligands and suggested the idea that their spectrum is likely to be much broader than was previously thought.
Exogenous dietary-derived ligands Aside from synthetic ligands, a variety of naturally occurring ligands from dietary sources directly activate and/or inhibit the AhR signaling pathway (Fig. 2) . As early as the 1970s, several studies had already demonstrated that vegetable extracts or vegetable-derived materials induce CYP1A1 activity. 39, 40 Cruciferous vegetables, such as broccoli and brussel sprouts, have been found to be rich sources of glucobrassicin, which generates indole-3-carbinol (I3C) and indole −3-acetonitrile (I3AC) by enzymatic cleavage during mastication. Both I3C and I3ACN are able to bind and activate AhR. [40] [41] [42] [43] Moreover, the ability of several dietary plant compounds, such as tryptophan, curcumin, and carotenoids, to bind AhR and/or induce AhR-dependent gene expression has also been reported. 35, [44] [45] [46] [47] Other naturally occurring dietary AhR ligands are flavonoids (Fig. 2) , which originate from plant-based foods, such as tea and fruits. Flavonoids are mostly AhR antagonists, but some of them, particularly quercetin, diosmin, tangeritin, and tamarixetin, are AhR agonists. [47] [48] [49] [50] [51] [52] One of the most interesting facts about these plant-derived AhR ligands is that they can be detected in human plasma in micromolar quantities, which are sufficient to inhibit/ activate AhR. 53, 54 Similar to synthetic compounds, these naturally occurring dietary-based AhR ligands have different structures, thus underscoring the heterogeneity of AhR ligands. It remains to be determined whether these dietary-derived AhR ligands have different downstream signaling effects and whether their different structure and physiochemical properties can be therapeutically exploited in different health care scenarios.
Endogenous ligands
The importance of AhR in normal development and host biochemical processes has been highlighted by studies using AhR knockout animals, which display numerous developmental and functional abnormalities. 55, 56 The lack of AhR activation by endogenous ligand(s) has been proposed to explain the functional alterations in AhR knockout mice; however, the identity of these putative compound/chemical(s) is not clear. 7 Nonetheless, the ability of some of the presumptive endogenous ligands to activate AhR has been confirmed in vitro, 7 but their specific role and physiological consequence in activating AhR in vivo remains to be confirmed and/or identified.
Indole and tryptophan metabolites Exogenous diet-derived indoles, such as tryptophan and glucobrassicin, are a major source of endogenous AhR ligand precursors. The conversion of these dietary-compound precursors into derivatives or byproducts through biochemical reactions or by metabolic activity of microorganisms, such as the intestinal microbiota, leads to the production of several important AhR ligands 40, 57 (Fig. 2 ). In the presence of stomach gastric acid, glucobrassicin, I3C, and I3ACN are susceptible to non-enzymatic acid condensation reactions to generate a number of AhR ligands, including 3,3′ diindolylmethane (DIM), 2-(indol-3-ylmethyl)−3,3′diindolyl-methane, and indolo [3,2-b] carbazole (ICZ) 35, 40, [58] [59] [60] (Fig. 2 ). Most indole derivatives are formed from the metabolism of tryptophan, which by itself is a form of indole, through various biological and physiochemical processes. In vitro and in vivo studies have shown that the byproducts of tryptophan photooxidation possess a high AhR-binding capacity and are able to induce the expression of Cyp1a1 and other AhR target genes. [61] [62] [63] [64] A prime example of a tryptophan photoproduct is a 6-formylindolo[3,2-b]carbazole (FICZ), which displays a significant structural similarity and potency to ICZ and can agonistically stimulate AhR activity in as low as picomolar ranges [65] [66] [67] (Fig. 2) . Aside from light exposure, some microorganisms can metabolize tryptophan into derivatives, such as indole acetic acid (IAA) and indole-3-acetaldehyde, both of which are AhR agonists [68] [69] [70] [71] [72] (a list of known microorganisms that produce AhR ligands is found in Table 1 ) (Fig. 2) . Some commensal bacteria, such as Escherichia coli, have up to three permeases for tryptophan transport and use tryptophan as a source of nitrogen. 68 Moreover, indole is transported in and out of bacteria by passive diffusion or active transport by AcrEF-TolC and Mtr transporters. 68, 73, 74 Another study showed that some strains of Lactobacillus reuteri and Lactobacillus johnsonii are able to produce indole-3-aldehyde (IAld) through the indole pyruvate pathway, which is catalyzed by the enzyme aromatic amino acid transferase. 71 intraepithelial lymphocytes (IELs) by metabolizing tryptophan in indole derivatives. 72 Recent reports have demonstrated the importance of microbiota-derived indoles in regulating homeostasis through AhR activation, emphasizing the critical role of AhR in host physiology. [75] [76] [77] Indigo and indirubin, both microbiota-derived tryptophan metabolites, have been isolated from human urine. A yeast-based AhR reporter assay showed that these tryptophan metabolites are almost equipotent as TCDD in their ability to activate AhR. 78 However, the capacity of indigo and indirubin to activate AhR seemed to be much lower using a mammalian reporter system, highlighting the limitations posed by bioassays that measure AhR activity.
Tryptophan can also be metabolized by host cells via the enzymes indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase, which generate AhR ligands, such as kynurenine (Kyn) and kynurenic acid 7, [79] [80] [81] (Fig. 2) . However, the Kyn concentration required to elicit reporter AhR activity in a hepatoma cell line casts doubt on its relevance as an AhR activator under physiological conditions. 78 Finally, serotonin and melatonin, two other tryptophan-derived biomolecules, are important neuroendocrine modulators, but their roles in activating AhR and the physiological consequence of this activation remain to be studied. Further work in this area may provide interesting insights into the AhR-dependent physiological effects of these tryptophan byproducts.
Other ligands Interestingly, some chemicals, such as caffeine, 82 nicotine, 83 and pyridines, 84 can induce AhR-dependent gene expression without binding to AhR [85] [86] [87] [88] [89] [90] (Table 2 ). These chemicals are not classical AhR ligands, but they may still have low-affinity binding capacity.
Indeed, carbaryl was previously reported to not bind AhR, 91, 92 but modifications of the AhR ligand-binding assay demonstrated that it is actually a weak AhR ligand. 37 As AhR activation affects a myriad of functions, it will be interesting to investigate the signaling pathways of these chemicals with ligand-independent AhR-activating properties to target specific AhR-related functions for health maintenance and disease prevention or treatment.
EVOLUTIONARY CONSIDERATIONS
AhR is evolutionary conserved across species. However, differential AhR activity and ligand reactivity exist across species, particularly between humans and murine animal models, which are often used for experimental purposes. [93] [94] [95] For instance, mouse AhR has ten times higher affinity to TCDD compared with human AhR. 96 In contrast, human AhR has higher affinity to indole derivatives compared with mouse AhR. 96 The ability of human AhR to react less to environmental toxins, such as TCDD, compared with putative beneficial AhR ligands, such as indole, is reassuring for human health. However, further studies are needed to confirm the effects of different AhR ligands. Furthermore, AhR is known to interact with Hsps and the AhRHsp interaction has been implicated in cancer pathogenesis. 97 AhR-Hsp interactions in humans, however, seem to be less stable than in mice, creating uncertainties in terms of the translational relevance of AhR-Hsp from murine findings. Human and murine AhR also share low transactivation domain sequence identity, 98 highlighting further evidence of the discrepancy between humans and murine models. As most AhR studies rely on murine animal models, there is a need to confirm and complement these results with human data. In the gastrointestinal tract, several reports have shown that AhR ligands modulate the development, function, production, and maintenance of several key mucosal immune cells and mediators. However, the exact molecular mechanisms are not well known. Moreover, depending on the context, the ligand, and the cell type involved, the effect of AhR modulation can vary.
Effect of AhR on intestinal epithelial cells and intestinal barrier function
The intestinal tract is the largest mucosal surface of the human body. It has a critical role in protecting the host from the environment, while maintaining proper nutrient absorption. The intestinal surface is lined by a single layer of intestinal epithelial cells (IECs), which forms a barrier between the intestinal lumen and the host's lamina propria (LP).
AhR influences different aspects of intestinal barrier function, from IEC proliferation to the production of IEC-derived molecules (Fig. 3) . Proliferation of colonic crypt stem cells is impaired in AhR -/ -mice, highlighting the fundamental role of AhR in epithelial cell renewal and turnover. 18 In terms of intestinal epithelial integrity, the AhR agonist FICZ had been shown to prevent hypoxia-driven barrier dysfunction of IEC in vitro. 102 In particular, AhR activation ameliorated the hypoxia-driven intestinal permeability by rectifying expression of the epithelial tight junction protein ZO-1. 102 Similarly, bacterialderived indole was able to increase epithelial tight junction integrity and reduce inflammation, 75 although it is still unclear whether this effect is AhR-mediated. Moreover, mice with intestinal epithelium-specific AhR deficiency were more sensitive than control mice to Dextran Sodium Sulfate (DSS)-induced intestinal inflammation and had enhanced apoptosis of epithelial cells, suggesting that AhR has an intrinsic role in IEC integrity. 103 Although it is significant to elucidate the direct impact of AhR on IEC, it is equally important to remember that AhR is expressed by other cell types, including immune cells (Fig. 3) . Consequently, the effect of AhR on IEC may also be indirectly mediated through signaling with other cell types. The most obvious example is the AhR-dependent production of IL-22 by immune cells that have major effects on IEC, inducing their proliferation and the production of antimicrobial peptides 104, 105 (Fig. 3) . Conversely, IEC may modulate the effects of AhR ligand on other cell types. Indeed, CYP1A1 deficiency in IEC has been shown to increase the availability of AhR ligands to immune cells, suggesting that IEC have a crucial role as gatekeepers for AhR ligand availability in the intestine. 106 Thus, reductionist in vitro studies that only involve IEC may not be sufficient to recapitulate the global effect of AhR on IEC. Studies using hematopoietic chimeras and conditional AhR knockout mice could be useful to determine the in vivo effect of AhR on different cell types and, notably, to discriminate the direct and indirect cellular effects of AhR signaling. Certainly, studies using murine models with conditional AhR gene deletion in dendritic cells (DCs) or IECs have demonstrated that AhR signaling in these cell types is dispensable for the normal development of intestinal lymphoid organs, such as cryptopatches and isolated lymphoid follicles, 107 but has an effect on other cell types, such as T cells.
Aside from their global effects on epithelial cells, AhR ligands influence the gene expression and protein production of specialized IEC types. 55 For instance, microbiota-derived indole induces the production of incretin and hormones by enteroendocrine cells. 108 Whether this is an AhR dependent response is not yet known, but it suggests the possible involvement of AhRrelated signaling in hormonal function of the epithelium.
AhR is involved in mucus production in the lung, suggesting that it may be similarly involved in mucin production in the intestine. 109 However, no study at this time has demonstrated the ability of AhR to regulate mucus production in the intestine. 18, 110 AhR deficiency in mice results in the loss of intestinal γδ T cells and TCRαβ CD8αα IELs in a cell-intrinsic manner, possibly through a reduced survival mechanism;
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110 this suggests the necessity of AhR signaling for postnatal IEL survival. As IELs are also involved in epithelial growth, 18 it follows that AhRdependent IEL maintenance contributes to IEC homeostasis and further suggests the indirect ability of AhR to regulate intestinal barrier function (Fig. 3) . Aryl hydrocarbon receptor and intestinal B Lamas et al.
In particular, both the production and function of a specific subgroup of ILCs, termed Group 3 ILC (ILC3), which includes lymphoid tissue inducer (LTi), natural cytotoxicity triggering receptor (NCR) + ILC3, and NCR-ILC3, are highly influenced by AhR activation 110, 118 (Fig. 3) . AhR deficiency in the hematopoietic compartment leads to profound loss of LTi and NCR + ILC3 in the intestinal LP and reduced IL-22 production. 110, 118, 119 ILC3 produce the cytokines IL-17 and/or IL-22 through the transcription factor RORγt, and the lack of ILC-derived cytokines, particularly IL-22, has been linked to different host pathologies, including infections and metabolic disorders. 119 In addition, IL-22, which is also produced by T cells (see below), is implicated in intestinal homeostasis, 71, 120 notably by inducing the expression and production of antimicrobial peptides, such as Reg3γ and Reg3β, 104, 105 by IEC (Fig. 3) . ILCs are also involved in the postnatal development of intestinal lymphoid follicles, including cryptopatches and isolated lymphoid follicles. responses by driving either Th17 or regulatory T (Treg) cells. 121, 122 These functions are partly modulated by the local environment, such as the presence of AhR ligands. 122, 123 In response to lipopolysaccharide (LPS), macrophages derived from AhR -/-mice showed an increase production of pro-inflammatory cytokines, 113 whereas the production of IL-10 by AhR -/-bone marrow-derived DCs (BMDCs) was decreased. 114 Moreover, the absence of AhR in BMDCs inhibits Treg development, facilitates Th17 generation from naive T cells and promotes naive T-cell proliferation in vitro. 114 AhR has also recently been identified as a molecular switch for monocyte fate, promoting differentiation toward DC while impairing differentiation into macrophages. 124 Combined, these studies suggest the ability of AhR to regulate the antiinflammatory responses of APCs. However, intestinal APCs are very specialized and are different from bone marrow-derived APCs used in these studies. Therefore, AhR could have different effects in intestinal APC subpopulations. An accumulation of plasmacytoid DCs was observed in lymph nodes of AhR -/-mice compared with wild-type (WT) mice. 123 Another study showed that the percentage of peritoneal monocyte-derived DCs was decreased after antibiotic treatment, which induced the loss of intestinal bacteria producing AhR ligands. 124 Moreover, an I3C-supplemented diet rescued monocyte-derived DC differentiation in antibiotic-treated mice. 124 These results suggest that AhR is a modulator of intestinal DCs, with potential indirect impacts on intestinal T cell responses (Fig. 3) . Intestinal DCs and macrophages are also involved in the AhR-mediated maintenance of intestinal epithelium integrity. Indeed, AhR deletion in CD11c-expressing intestinal mucosal DCs and certain macrophage subsets led to increased numbers of epithelial stem cells and goblet cells but decreased numbers of Paneth cells in the small intestine. 125 Moreover, as intestinal DCs and macrophages produce IL-23, these cells participate also to AhR-mediated maintenance of intestinal homeostasis and protection against infection. Indeed, after contact with microbial product, intestinal DCs and macrophages produce, independently of AhR, the cytokine IL-23, which mediates, in association with AhR signaling, the production of IL-22 by ILCs and T cells 118, [126] [127] [128] [129] [130] (Fig. 3) . Finally, AhR is also involved in neutrophil functions, particularly cytokine production. IL-17 and IL-22 production by neutrophils is also mediated by IL-23 through AhR and RORγt. 117 This is of particular importance in the context of intestinal homeostasis, because the protective effects of neutrophils in colitis are at least partly mediated by their production of IL-22. 116, 117 Comprehensively, these studies highlight the critical role of AhR in orchestrating innate immune responses and homeostasis in the intestine.
T cells. In addition to innate immune responses, AhR is involved in coordinating adaptive mucosal immune responses and homeostasis. AhR is highly expressed in Th17/22 cells, weakly expressed in Foxp3 + Treg cells and almost undetected in Th1 or Th2 cells. 111, 131 Similar to ILCs, AhR is also essential for IL-22 production by T cells. In vitro studies showed that AhR promotes Th17 cell differentiation and the production of IL-17 and IL-22 by γδ T cells. 132, 133 In contrast, AhR expression is reduced in pathogenic Th17 cells, which promotes tissue inflammation, 134 and T cells from AhR -/-mice develop Th17 responses but lack the ability to produce IL-22, 131 suggesting the capacity of AhR to modulate inflammatory responses. It is important to remember that, beyond its inflammatory pathology connotation, Th17 cells are important drivers of health, especially as they provide barrier protection and are involved in pathogen defense. 111 As reviewed below, the AhR-mediated Th17 response is one key factor in immune defense against infections. It is important to note that intestinal T cells are specialized and different from T cells generated in vitro or isolated from the spleen, which are used in the majority of studies exploring the role of AhR in T cells.
The deletion of AhR in T cells attenuated colitis by suppressing Th17 cell infiltration into the LP. 103 Moreover, differences in the frequencies of intestinal effector T cell subsets were observed in AhR -/-mice compared with WT mice after DSS treatment. 135 The percentage of Th17, Th1, and Tc1 (type1 CD8 ± T cells) but not Tc17 (IL-17 ± CD8 ± T cells) was increased in the colonic LP of AhR -/-mice compared with WT mice. 135 In the small intestine, elevated frequencies of Th17 and Tc1 were also observed in AhR -/-mice. 135 These results show that the AhR pathway has an intrinsic role in T-cell functions, particularly in the intestinal mucosa (Fig. 3) .
In the last decade, several mechanisms of actions by which AhR promotes the expression of IL-17 in Th17 cells have been proposed. 132, 133, 136 Regarding the role of AhR in the induction of IL-22 production by T cells, an interaction with the transcription factor RORγt has been identified. Indeed, chromatin immunoprecipitation assay showed that AhR is recruited to IL-22 locus when HEK293T cells coexpress RORγt 118 . A study using thymoma cell lines provided clues that cooperation between AhR and RORγt may be involved in the induction of IL-22 expression. 118 IL-22 expression by T cells might also be regulated other cytokines. Indeed, effects of IL-6 and IL-21 on Th22 cells generation seems to be AhR-independent and AhR-dependent respectively. 137, 138 AhR also participates in intestinal homeostasis by regulating the generation and function of Treg cells. 139 Consistent with the importance of AhR in gut tissue-associated Treg cells, 139 high amounts of AhR have been observed in Treg cells from the gut compared to Tregs from other anatomical locations. 140 Expression of the transcription factor Foxp3, which drives Treg differentiation and function, is decreased in AhR -/-mice. 141 Moreover, AhR activation by agonists induced Foxp3 expression and promoted Treg differentiation. 139, 142, 143 In contrast, no increase in Treg differentiation or function has been observed in mice with constitutive AhR activation, 144 suggesting a complex regulatory system. Thus, the exact role of AhR in Treg differentiation and function remains controversial and warrants further studies.
The type 1 Treg cells (Tr1) subset also expresses AhR. Tr1 cells express IL-10 but not Foxp3 and are prominent in chronic infections and other specific immune-related manipulations, such as peptide immunization or anti-CD3 activation. 145 IL-10 and IL-21 production by Tr1 is controlled by AhR via interaction with the transcription factor c-Maf. 146 Interestingly, AhR activation, in the presence of TGF-β, can promote the differentiation of Th17 cells into Tr1 cells, 147 underscoring the role of AhR in T-cell plasticity. Collectively, these data demonstrate that AhR has an important role in intestinal homeostasis by directly and indirectly modulating the function of epithelial cells and many immune cell subtypes. Although AhR activation appears to be essential at basal homeostatic state, its protective role is more clearly unmasked in altered settings such as intestinal inflammation or infection.
ROLE OF AHR IN INTESTINAL PATHOLOGICAL CONTEXT
AhR signaling regulates the composition and function of different cell types in the gastrointestinal tract and has a pivotal role in maintaining the balance between health and disease. Because of its numerous functions, AhR has been implicated in several intestinal pathologies. The following section highlights the role of AhR in intestinal inflammation, infection and cancer.
AhR in gut inflammation
Accumulating evidence has shown that AhR has an important role in the regulation of the immune response to Crohn's disease (CD) and ulcerative colitis (UC), which are the two main subtypes of inflammatory bowel disease (IBD). The pathogenesis of IBD is unclear but involves an exaggerated intestinal immune response toward the gut microbiota in genetically susceptible hosts.
AhR gene and protein expressions are lower in inflamed tissue from CD patients, but not UC patients, compared with uninflamed tissues and healthy controls 148 (Fig. 4) . However, other studies have shown that, unlike AhR protein expression, which is decreased in inflamed CD tissues, there is no difference in AhR gene expression between tissues from CD patients and healthy controls. 149 The involvement of post-transcriptional mechanisms may explain the disparity between AhR gene and protein expression. This is consistent with a study showing that miRNA-124, which is involved in post-ranscriptional gene regulation and had been shown to have a pro-inflammatory role in TNBS-induced colitis by suppressing AhR, is highly expressed in inflamed biopsies and IECs from CD patients. 150 The importance of AhR in intestinal homeostasis is underscored by murine studies showing that AhR deficiency increases the immunopathology of DSS-and T-cell transfer-induced colitis. 110, 112 Interestingly, immune cells from IBD patients, particularly CD patients, tend to express low levels of AhR. For instance, flow cytometry analysis of the LP mononuclear cells demonstrated that the expression of AhR in CD3 + , CD4
+ , CD56 + , and CD25 + cells is decreased. 148 Similarly, the expression of AhR in NKp44 + ILC3s cells from the inflamed intestinal biopsies of CD patients was lower compared to ILC3 from unaffected tissues. 151 The cause for this downregulation is unknown. However, as AhR ligands, especially those that are microbiota derived, have been shown to be impaired in IBD patients, 152 it is tempting to hypothesize that decreased AhR expression in immune cells is related to decreased ligand availability (Fig. 4) .
Administration of AhR agonists and antagonists in different animal models of colitis has also been utilized to elucidate the role of AhR in gut inflammation. After FICZ treatment, the severity of Trinitrobenzenesulfonic acid (TNBS)-, DSS-, and T-cell-transferinduced colitis in mice significantly decreased, which was characterized by down-regulation of pro-inflammatory cytokines and production of IL-22. 148, 152 In contrast, treatment of mice with an AhR antagonist reduced IL-22 production and enhanced the severity of inflammation in a murine model of TNBS-induced colitis. Moreover, administration of anti-IL-22 prevented the antiinflammatory effect of FICZ, suggesting that the therapeutic effect of FICZ, at least in this colitis model, is partially mediated by IL-22. 148 Moreover, oral administration of the AhR agonist β-naphthoflavone decreased DSS-induced colitis severity and the production of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, IL-6, and IL-1β. 153 The severity of DSS-induced colitis was also attenuated by the toxic synthetic AhR ligand TCDD, presumably through up-regulation of colonic PGE2 production. 154 The TCDD effects were further attributed to increased differentiation of Tregs and decreased induction of Th17 cells through epigenetic regulation. 155 Activation of AhR using the non-toxic agonist 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) similarly induced human Tregs in vitro. 142 Moreover, in a humanized mice model, where human CD4 + T cells drive TNBS-induced colitis, ITE administration ameliorated colitis severity by upregulating CD39-expressing Granzyme B and IL-10-secreting human Tregs. 142 The effect of AhR ligands in reversing inflammatory responses has also been demonstrated in a clinical setting. In fact, treatment of LP mononuclear cells from CD patients with the AhR agonist FICZ resulted in decreased IFN-γ expression and up-regulation of IL-22. 148 Overall, these studies highlight the important role of AhR signaling in modulating intestinal inflammation (Fig. 4) .
As indicated above, some AhR ligands are byproducts of tryptophan metabolism by the gut microbiota; these derivatives have been shown to modulate the intestinal immune response. Recently, our group demonstrated that dysbiotic microbiota from mice deficient for Caspase recruitment domain 9 (CARD9), one of the numerous IBD susceptibility genes, fails to metabolize tryptophan, leading to defective production of AhR agonists. 152 This defect led to impaired IL-22 production and ultimately contributed to the increased susceptibility of Card9 -/-mice to DSS-induced colitis. 152 FICZ administration was effective in rescuing the IL-22 defect and subsequently decreasing the susceptibility of Card9 -/-mice and of germ-free WT mice colonized with Card9 -/-microbiota to colitis. 152 Similar to what was observed in Card9 -/ -mice, feces of patients with IBD, particularly in those with CARD9 risk alleles, showed impaired AhR agonist activity, consistent with decreased concentrations of the indole derivative IAA. 152 No association was observed among other major IBD-associated loci, including NOD2, ATG16L1, and LRRK2, 152 suggesting a specific connection between IBD, CARD9, and the ability of the microbiota to produce AhR agonists. Likewise, the AhR-IL-22 axis shapes the microbiota to produce AhR ligands and consequently is involved in the maintenance of gut immune homeostasis. Administration of exogenous IL-22 was sufficient to normalize AhR ligand production and colitis susceptibility in Card9 -/-mice, suggesting a vicious circle between the AhR ligand defect and IL-22 defect. 152 Abundance of segmented filamentous bacteria (SFB), a major driver of Th17 cell development in the intestine, 156, 157 is regulated by IL17 signaling in epithelial cells. 158 IL-22 production by AhR + RORγt + ILC has also been shown to be crucial to control SFB colonization and the Th17 cell response. 112 Decrease IL-22 production due to the loss of ILC3 in AhR -/-mice was associated with SFB outgrowth and enhanced Th17 responses, 112 suggesting that AhR-dependent ILC3 survival, and consequently its IL-22 production, has an important role in shaping the gut microbiota and in intestinal homeostasis (Fig. 4) . Certain bacteria and fungi can metabolize tryptophan into indole derivatives (Table 1) ; 71, 152, 159, 160 henceforth, these microorganisms are attractive candidates to be used as next generation probiotics to reduce intestinal inflammation. In fact, a recent study from our group demonstrated that administration of three Lactobacillus strains (L. murinus, L. reuteri, and L. taiwanensis) isolated from the feces of WT mice for their ability to activate AhR was efficient in rescuing the impaired IL-22 production and susceptibility to DSS of germ-free WT mice colonized with Card9 -/-microbiota. 152 These effects were mediated by AhR, as they were abrogated in the presence of an AhR antagonist. 152 Moreover, Propionibacterium freudenreichii ET-3, isolated from Swiss-type cheese, has been shown to produce the AhR agonist 1,4-dihydroxy-2-naphthoic acid, which can induce expression of the intestinal anti-microbial peptides Reg3γ and Reg3β and can improve DSS-induced colitis in mice. 160 Lactobacillus bulgaricus OLL1181 is also able to activate the AhR pathway and improve DSS-induced colitis. 154 Overall, these studies emphasize the importance of microbiota-derived AhR ligands in modulating intestinal inflammation (Fig. 4) .
In recent years, specific lifestyle choices or diet have been proposed as contributing factors in the rising inflammatory diseases in developed countries. As detailed above, AhR activators can also be derived from diet. Hence, it is possible that insufficient sources of AhR ligands may underlie how certain diets can influence the evolution of inflammatory diseases (Fig. 4) . As diet can modulate intestinal microbiota composition, 161, 162 it may contribute to inflammatory disease by changing the capacity of the microbiota to produce AhR ligands. Accordingly, a tryptophanfree diet altered gut microbiota and increased the susceptibility of animal models to DSS-and TNBS-induced colitis. 163 On the other hand, a tryptophan-containing diet decreased DSS-induced colitis severity 164, 165 and regulated epithelial homeostasis through AhR activation. 165 Henceforth, activation of the AhR pathway by dietary-derived tryptophan derivatives, such as indoles, and/or probiotics organisms that produce AhR ligands offers exciting promise for future therapies in IBD and other diseases where individuals have dysbiotic microbiota with defective production of AhR agonists.
AhR and intestinal infection
In association with innate and adaptive immunity, the microbiota controls resistance against colonization by intestinal pathogens. AhR ligand activation induces key immune responses, notably IL-22 production, that are critical for intestinal pathogen clearance (Fig. 5) . Indeed, AhR deficiency in mice results in higher susceptibility to Citrobacter rodentium, 106, 107, 112, 126 which is a natural mouse pathogen widely used to mimic human infections caused by enteropathogenic E. coli and enterohemorrhagic E. coli. 166 AhR regulates host immunity to C. rodentium in an IL-22-dependent manner, as AhR -/-mice fail to produce IL-22, 106, 107, 112, 126 and ectopic expression of IL-22 protects AhR -/-mice from this pathogen. 112 Moreover, AhR and IL-23R-mediated IL-22 production of ILC3 are essential for shaping the microbiota to mediate early colonization resistance against C. rodentium infection 167 ( Fig. 5 ). Higher susceptibility to C. rodentium is similarly observed in R26 Cyp1a1 mice, where constitutive Cyp1a1 expression depletes the reservoir of natural AhR ligands and generates a quasi AhR-deficient state. 106 Administration of recombinant IL-22 or an I3C-supplemented diet reduced bacterial burden and prolonged the survival of R26 Cyp1a1 mice. 106 Conversely, deletion of the three AhR-controlled CYP enzymes CYP1A1, CYP1A2, and CYP1B1 had the opposite effect. 106 
AhR
-/-mice are hypersensitive to LPS-induced septic shock, suggesting that AhR may also be involved in immune responses toward other Gram-negative bacteria. 116, [168] [169] [170] Specifically, upon LPS treatment, the serum levels of IL-6, IL-1β, and TNF-α in AhR -/-mice increased, whereas the level of IL-10 decreased compared with WT controls. 116, [168] [169] [170] In conjunction, macrophages from AhR -/-mice secreted higher IL-6, IL-1β, and TNF-α levels in response to LPS than WT mice. 132, 169 AhR-dependent repression of IL-6 production following LPS stimulation in macrophages depends on two independent mechanisms: (i) suppression of histamine production via the histamine 1 receptor signaling 169 and (ii) formation of an AhR-Stat1 complex inhibiting NF-kB transcriptional activity in their promoter region. 171 AhR activation also enhances the expression of plasminogen activator inhibitor-2 (Pai-2), an inhibitor of caspase-1 activation, which suppresses the production of IL-1β in response to LPS treatment in macrophages. 168 The protective effect of AhR activation is not restricted to LPS or Gram-negative bacteria-induced immunopathology. Rather, the same response is similarly observed for Gram-positive intestinal pathogens. Listeria monocytogenes, which is often used as model intracellular pathogen, is a facultative bacterium that causes foodborne disease, considerable morbidity and a relatively high mortality rate. AhR deficiency in mice results in higher susceptibility to L. monocytogenes, 172 despite increased production of proinflammatory cytokines, such as IL-6 and TNF-α, by macrophages after infection. 113 Moreover, administration of FICZ protects against L. monocytogenes infection. 171 Although AhR signaling is indispensable for optimal resistance to L. monocytogenes infection by improving macrophage survival and ROS production, 171 AhR is not essential for the adaptive immune response to L. monocytogenes.
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AhR is also involved in response to Clostridium difficile, which is a ubiquitous, anaerobic, spore-forming Gram-positive bacterium. Only toxigenic strains have pathogenic potential, and microbiota alterations after antibiotic use is a major risk factor for C. difficileassociated infection in humans. Supplementation of a semipurified diet with I3C reduces the severity of C. difficile infection in WT and AhR -/-mice, suggesting that the effects of I3C may be mediated by both AhR-dependent and independent mechanisms. 173 At least in WT mice, I3C diet-mediated protection against C. difficile infection was due to increased populations of cecal Treg, ILC3, γδ T cells, and neutrophils before infection. 173 In addition to its protective effect against intestinal pathogenic bacteria, AhR is also involved in resistance to fungi. Administration of IAld, a bacteria-derived AhR ligand, to Candida albicans-infected WT mice induced IL-22 production by colonic NKp46 + cells, which enhanced resistance to fungi. These effects were mediated by AhR, as they were lost in AhR -/-mice. 71 Colonization of conventional mice treated with antibiotics or GF mice by IAldproducing L. reuteri before C. albicans infection also improved resistance to fungi via induction of IL-22. 71 Moreover, indole and its derivate indole-3-acetonitrile inhibited C. albicans biofilm formation in vitro, as well as C. albicans filamentation and attachment to IECs. 174 These studies suggest that AhR activation by its ligands may be a potential therapeutic target for bacterial and fungal intestinal infection.
AHR AND COLORECTAL CANCER
Emerging evidence has indicated that AhR also has an important role in intestinal tumorigenesis regulation. However, due to the pro-and anti-carcinogenic properties of AhR, its role remains controversial. AhR deficiency in mice results in enhanced formation of spontaneous colonic polyps and cecal tumors. 175, 176 The suppression of intestinal tumor development by AhR is dependent on β-catenin degradation and on apoptosis-associated speck-like protein containing a caspase recruitment protein (ASC), which has an essential role in caspase-1 activation in inflammasomes, 176 but not on the adenomatous polyposis coli system. 176 Moreover, AhR regulates Pai-2 gene expression through a mechanism involving NF-κB to suppress caspase-1 activation, 168 resulting in negative regulation of IL-1β secretion. 177 In AhR -/-mice, cecal tumorigenesis is decreased after blocking IL-1β signaling with a caspase-1 inhibitor. 55 Interestingly, no cecal tumors were observed in germ-free AhR -/-mice, suggesting a key role of the gut microbiota in cecal tumor development in AhR -/-mice. 176 Compared with conventional AhR -/-mice, AhR
double knockout mice exhibit reduced tumor development, suggesting that AhR acts as a tumor suppressor in inflammation-associated intestinal neoplasia. 176 Compared with Apc Min/+ mice, which develop cecal and small intestinal tumors, Apc Min/+ /AhR +/-mice have increased tumor incidence, 175 suggesting a tumor suppressor role of AhR in non-inflammatory intestinal carcinogenesis. AhR expression is elevated in tumor tissues from human colon cancer and Apc Min/± mice compared with normal tissues. 178 Moreover, small interfering RNA-mediated AhR knockdown in human colon cancer cell lines (HCT116 and HT29) leads to enhanced cell growth, whereas treatment with various AhR ligands, such as methylcholanthrene, I3C and DIM, inhibits cell proliferation, confirming that AhR acts as a tumor suppressor, at least partly through direct effects on tumor cells. 178 In human and Apc Min/± mice colon cancer tissues AhR is localized to both stromal and tumors cells, whereas in normal intestines AhR is localized to stromal cells, the LP, and lymphoid follicles that contain immune cells, suggesting a potential role of AhR through effects on stromal cells. 178 In vitro, DIM and ICZ are also able to stimulate apoptosis in human colon LS-174 and Caco-2 adenocarcinoma cell lines but not in a non-transformed human colon epithelial cell line. 179 Pretreatment with a combination of ICZ and isothiocyanate sulforaphane (SUL) reduced DNA damage in LS-174 cells treated with benzo(a)pyrene or H 2 O 2 . 179 However, it remains to be proven whether protection against DNA damage conferred by ICZ and SUL is dependent on AhR. Diets containing AhR ligands, such as I3C and DIM, reduce the number and incidence of intestinal tumors by β-catenin degradation in Apc Min/+ mice. 175 Treatment
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with DIM also decreases the number of colon tumors in colitisassociated carcinogenesis induced by azoxymethane/DSS in WT mice. 180 These studies all suggest that AhR has distinct roles in tumor suppression by regulating the gut immune system in normal tissues and negatively regulating tumor growth in the context of cancer.
Although these studies indicate that AhR ligands have anticarcinogenic properties, some studies have likewise demonstrated pro-carcinogenic effects of AhR ligands. Different studies have shown increased expression of AhR in tumor cells of several human cancers, including prostate, 181 lung, 182 breast, 183 pancreatic, 184 and gastric cancer, 185 and have designated AhR an anticancer target. The overexpression of CYP1A1 and CYP1B1 in human colon tumors also suggests activation of AhR. 186 Moreover, expression of a constitutively active AhR in transgenic mice was found to induce stomach tumors. 187 However, AhR is expressed by other cell types, including immune cells, which have an anti-tumor role. Consequently, the effect of constitutive AhR expression on stomach tumor induction may also be indirectly mediated through signaling by other cell types. In contrast to the antiproliferative effect induced by the AhR agonists DIM and ICZ, 178, 179 TCDD induces phosphorylation of Src kinase, leading to activation of the epidermal growth factor receptor and downstream ERK1/2 signaling, which eventually enhances colon cancer cell proliferation. 188 These in vitro results suggest that the pro-and anti-proliferative properties of AhR could be dependent on the AhR ligand used. Different growth factors, including TGF-β and TNF-α, are downstream targets of AhR signaling pathways and thus could also be involved in the pro-proliferative effect of AhR. 23, 186, 189, 190 In addition to these proliferative effects, AhR activation is involved in pro-carcinogenic effects by inducing expression of pro-inflammatory IL-1β, matrix metalloproteinase-9 (MMP-9), and the BCRP/ABCG2 drug transporter in colon cancer cells. 191 For instance, IL-1β is associated with the induction of MMP and is known to increase cancer cell growth and metastasis. 192 In addition, increased expression of BCRP/ABCG2 has been observed in a number of cancer cells that develop drug resistance against chemotherapeutic compounds.
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Interestingly, most in vitro studies have shown that AhR ligands enhance colon cancer cell proliferation, whereas most in vivo studies have shown protective effects of AhR against intestinal cancer. These contradictory effects suggest that in vitro studies to determine the impact of AhR on colon carcinogenesis may not be appropriate; thus, further studies are needed to characterize the impact of AhR on colon carcinogenesis. Furthermore, the majority of in vitro studies have focused on the impact of AhR on cancer cells, whereas AhR is expressed by many cell types, including immune cells, which have a major anti-tumor role. Moreover, inflammation alone may lead to tumor formation. Consequently, AhR could also indirectly regulate colon carcinogenesis through its effects on immune cells. This could explain the differences observed between in vitro and in vivo results. Studies using hematopoietic chimeras or conditional knockout mice could be useful to determine, in vivo, whether the role of AhR in colon carcinogenesis is intrinsic to epithelial cells or is mediated by immune cells.
Collectively, despite some conflicting in vitro results, these data suggest that activation of the AhR pathway by dietary or microbiota-derived AhR agonists could be a target of preventive or therapeutic strategies against colorectal cancer.
CONCLUSION
AhR ligands, derived from food, intestinal microbiota, and environmental contaminants, are naturally enriched within the gastrointestinal tract. AhR is expressed by different cell types in the gut, including immune cells and IEC, and has a pivotal role in regulating a myriad of cellular host functions. It logically follows that AhR, especially when its activation is perturbed, could influence the progression and outcome of different diseases. Data from animal models, maintained under diets containing or deficient for AhR ligands, support the complex roles of AhR in the regulation of intestinal homeostasis, particularly in regard to immune aspects. Disruption of intestinal homeostasis has been described in different intestinal inflammatory diseases; available data from both animal models and mammalian cell lines suggest the remarkable potential of dietary-derived AhR agonists, indole derivatives and/or AhR ligand-producing probiotic organisms as preventive and therapeutic interventions. Modulating the AhR pathway is also an attractive curative strategy for other intestinal pathological conditions, such as infection and colorectal cancer. However, the origin and structure of AhR ligands are diverse and their effects are not similar, likely due to their differential receptor affinity and downstream signaling effects. Therefore, further studies are needed to better understand the complex role of AhR in the regulation of intestinal homeostasis, and safely and efficiently target it as a preventive and therapeutic approach.
